Asthma  >>  QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva
2004-001928-20: Open-label, multi-centre study to compare the effectiveness of QvarTM Autohaler therapy with conventional therapy (similar doses) in children with stable asthma

 
4
300
Europe
Qvar 100µg Autohaler, Inhalation vapour, solution, Qvar 100µg Autohaler
UCB Pharma Belgium
Children aged 7 - 12 with stable mild persistent to moderate persistent asthma (according to the GINA classification)
 
 
OLiVIA, NCT01741285 / 2012-005350-39: Effects of QVAR in Smokers With Asthma

Completed
4
40
Europe
Beclomethasone (QVAR), QVAR, Beclomethasone (Clenil), Clenil, Fluticasone, Flixotide
University Medical Center Groningen, Teva Pharma
Asthma
07/15
12/15
NSRS, NCT02294279: The Evaluation of FeNO for Predicting Response to ICS in Subjects With Non-specific Respiratory Symptoms

Completed
4
360
Europe
Qvar (100 mcg), Beclomethasone diproprionate
Research in Real-Life Ltd, Aerocrine AB
Asthma
08/16
08/16

Download Options